Category Specific RSS

News

Quickstep jumps post contracts update and takeover offer

Quickstep Holdings (ASX:QHL) has had a busy day, announcing (1) the successful finalisation of key negotiations with its Tier 1 defence customers, incorporating terms that reflect mutually acceptable volumes and pricing adjustments and (2) a takeover offer from ASDAM Operations Pty Limited.

  • Contracts update
  • C-130 Program with Lockheed Martin: Quickstep Holdings secures volume and increased pricing for the C-130 program post-MYIII contract, covering deliveries from February 2025 to December 2029 with pricing adjustments effective from February 2025
  • F-35 Vertical Tail Program with Marand: Quickstep Holdings concludes agreements for vertical tail component production. The contract spans production from September 2024 to June 2026, with pricing adjustments effective from September 2024
  • F-35 Program with Northrop Grumman: Quickstep Holdings receives Lot 19 definitised purchase order firming the demand for FY26 to FY27 H1 component production
  • Quickstep Holdings also remains in active discussions with Northrop Grumman regarding further pricing adjustments for the new orders, ensuring alignment with current economic conditions.
  • Takeover offer
  • ASDAM Operations Pty Limited intends to make an off-market takeover bid for Quickstep Holdings at a cash price of A$0.40 per share
  • The latter price is 105% above the closing price of $0.195 at the end of trading on 6 November 2024
  • The Offer is subject to only three conditions, one being a minimum 90% acceptance by Quickstep shareholders
  • ASDAM had previously submitted an offer to Quickstep to acquire 100% of the Company by way of a scheme of arrangement, and was still open to transacting via Scheme

Rohan Stocker, ASDAM CEO, said: “As one of Quickstep’s largest customers, through Marand, ASDAM wants to work constructively with the Quickstep Board to conclude a value-creating deal for shareholders”.

Tim Grey

Recent Posts

AROA secures 2027 US reimbursement certainty for Symphony products

Reimbursement certainty remains an important factor in the adoption of advanced wound care products across…

49 minutes ago

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

2 months ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

2 months ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

3 months ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

6 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

6 months ago